(Q37593181)

21 August 2017

1 reference

title

Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse (English)

1 reference

21 August 2017

0 references

1 reference

3

P J Goadsby

1 reference

21 August 2017

5

G Bussone

1 reference

21 August 2017

H-C Diener

1

1 reference

21 August 2017

D W Dodick

2

1 reference

21 August 2017

M E Bigal

4

1 reference

21 August 2017

S D Silberstein

6

1 reference

21 August 2017

N Mathew

7

1 reference

21 August 2017

S Ascher

8

1 reference

21 August 2017

J Morein

9

1 reference

21 August 2017

J F Hulihan

10

1 reference

21 August 2017

D M Biondi

11

1 reference

21 August 2017

S J Greenberg

12

1 reference

21 August 2017

language of work or name

English

0 references

publication date

23 April 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

1021-1027

1 reference

Is migraine a progressive brain disease?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Factors associated with the onset and remission of chronic daily headache in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Clinical practice. Chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate in the Treatment of Chronic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Efficacy of topiramate and valproate in chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Analgesic overuse among subjects with headache, neck, and low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Does chronic daily headache arise de novo in association with regular use of analgesics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Features of medication overuse headache following overuse of different acute headache drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Cognitive-behavioral issues in the treatment and management of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Preventing chronicity of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Opiate use to control bowel motility may induce chronic daily headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Clinical features of withdrawal headache following overuse of triptans and other headache drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Probable medication-overuse headache: the effect of a 2-month drug-free period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Placebo effect and clinical trials in migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

A quantification of the placebo response in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Placebo response in clinical randomized trials of analgesics in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Placebo response in a patient with chronic migraine and ergotic overuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

Lessons from placebo effects in migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01859.X

10.1111/J.1468-2982.2009.01859.X

21 January 2018

Identifiers

DOI

1 reference

release_4bej263gjrdmnflh2oclwovklu

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4bej263gjrdmnflh2oclwovklu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference